These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
51 related items for PubMed ID: 3187930
21. Resolution of monomeric and heterodimeric forms of tissue factor, the high-affinity cellular receptor for factor VII. Morrissey JH, Revak D, Tejada P, Fair DS, Edgington TS. Thromb Res; 1988 May 15; 50(4):481-93. PubMed ID: 3413716 [Abstract] [Full Text] [Related]
22. Affinity chromatography in purification of A1 adenosine receptors. Nakata H. J Chromatogr; 1992 Apr 24; 597(1-2):335-43. PubMed ID: 1517337 [Abstract] [Full Text] [Related]
23. Purification and some properties of the protein component of tissue thromboplastin from human brain. Bjorklid E, Storm E. Biochem J; 1977 Jul 01; 165(1):89-96. PubMed ID: 889578 [Abstract] [Full Text] [Related]
24. Affinity purification and characterization of recombinant human galectin-1. Fouillit M, Lévi-Strauss M, Giudicelli V, Lutomski D, Bladier D, Caron M, Joubert-Caron R. J Chromatogr B Biomed Sci Appl; 1998 Feb 27; 706(1):167-71. PubMed ID: 9544819 [Abstract] [Full Text] [Related]
25. Immunoaffinity purification of bovine factor VII. Bach R, Oberdick J, Nemerson Y. Blood; 1984 Feb 27; 63(2):393-8. PubMed ID: 6362751 [Abstract] [Full Text] [Related]
30. The protein component of human brain thromboplastin. Bjorklid E, Storm E, Prydz H. Biochem Biophys Res Commun; 1973 Dec 10; 55(3):969-76. PubMed ID: 4761090 [No Abstract] [Full Text] [Related]
31. Radioimmunoassay of human tissue factor. Andoh K, Kubota T, Kobayashi N, Maekawa T. Thromb Res; 1986 Aug 01; 43(3):275-86. PubMed ID: 3738865 [Abstract] [Full Text] [Related]
32. An inhibitory monoclonal antibody against human tissue factor. Carson SD, Ross SE, Bach R, Guha A. Blood; 1987 Aug 01; 70(2):490-3. PubMed ID: 3607285 [Abstract] [Full Text] [Related]
33. Thromboplastic activity of acetone-dehydrated chicken brain powder extracts after repeated extraction and dilution. Shum YS, Griminger P. Poult Sci; 1972 Mar 01; 51(2):402-7. PubMed ID: 4643113 [No Abstract] [Full Text] [Related]
34. [Obtaining active extracts for use in production of soluble thromboplastin]. Tarasova LN, Repniakova EM, Vladimirova SG, Savinykh EIu. Klin Lab Diagn; 2004 Jul 01; (7):21-4. PubMed ID: 15372881 [Abstract] [Full Text] [Related]
35. The development of monospecific antibodies against human thromboplastin apoprotein (apoprotein III) and their application in the immunocytochemical detection of the antigen in blood cells. Bjørklid E, Holm T, Osterud B. Thromb Res; 1987 Mar 01; 45(5):609-24. PubMed ID: 2438802 [Abstract] [Full Text] [Related]
38. [On the importance of concentration and activity of tissue thromboplastin]. PUDLAK P. Cas Lek Cesk; 1961 Nov 10; 100():1409-13. PubMed ID: 14489124 [No Abstract] [Full Text] [Related]
39. Spontaneous Increase in Potency of Thromboplastin From Acetone-extracted Brain Tissue. Aggeler PM, Leake TB, Talbot JC. Science; 1948 Nov 05; 108(2810):507-9. PubMed ID: 17808929 [No Abstract] [Full Text] [Related]
40. Purification of human brain tissue factor. Kang S, Niemetz J. Thromb Haemost; 1988 Jun 16; 59(3):400-3. PubMed ID: 3187930 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]